L5.8 Kilder

Bupropion

SPC-omtalen på www.legemiddelverket.no

Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, Carrasco JL, Stahl S.The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J. Psychopharmacol. 2007 Jul; 21(5): 461–71.

Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. Clin. Ther. 2005 Nov: 27(11): 1685–95.

Høiseth G, Haslemo T et al. Effect of CYP2B6*6 on Steady-State Serum Concentrations of Bupropion and Hydroxybupropion in Psychiatric Patients: A Study Based on Therapeutic Drug Monitoring Data. Ther Drug Monit. 2015; 37(5): 589-93.

Antidepressiva

Berle JØ, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O. Breast-feeding during maternal antidepressant treatment with serotonin reuptake inhibitors: Infant exposure, clinical symptoms and cytochrome P-450 (CYP) genotypes. The Journal of Clinical Psychiatry 2004; 65: 1228-1234.

Berle JØ, Spigset O. Antidepressant use while breastfeeding. Current Women’s Health Reviews, 2011; 7: 28-34.

Berle JØ, Spigset O. Maternal antidepressant use and breastfeeding. Current Medical Literature – Psychiatry 2008; 19: 33-37.

LeNoury J. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015; 351: h4320. 

Information for Clinicians and Researchers. Mood disorders research program. The New York State Psychiatric Institute. Columbia University Department of Psychiatry. Specializing in Treatment and Research of Chronic Depression. Q&A About Sexual Side-Effects of SSRI Antidepressant Medications. http://www.depressionny.com/q&a-sexualse.htm (05.11.2017).

Westergren T, Narum S, Klemp M. Critical appraisal of adverse effects reporting in the ‘Treatment for Adolescents With Depression Study (TADS)’. BMJ Open 2019;9:e026089. doi:10.1136/ bmjopen-2018-026089

Hicks JK, Swen JJ, Thorn CF, Sangkuhl K, Kharasch ED, Ellingrod VL, Skaar TC, Müller DJ, Gaedigk A, Stingl JC; Clinical Pharmacogenetics Implementation Consortium. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther. 2013 May;93(5):402-8. doi: 10.1038/clpt.2013.2. Epub 2013 Jan 16. PMID: 23486447; PMCID: PMC3689226.

Antipsykotika

Leucht S et al. Comparative effi cacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382: 951-62.

Nalokson

Nalokson nesespray Nyxoid SPC http://www.ema.europa.eu/docs/no_NO/document_library/EPAR_-_Product_Information/human/004325/WC500240205.pdf

Naltrekson

Ringerike T, Pike E, Nevjar J, Klemp M. Bruk av naltrekson i lave doser utenfor godkjent bruksområde. Rapport fra Kunnskapssenteret nr. 8 – 2015. ISBN 978-82-8121-952-6 ISSN 1890-1298.

Raknes G, Simonsen P, Småbrekke L. The effect of Low Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental before-and-after Prescription Database Study. J Crohns Colitis 2018, , jjy008, https://doi.org/10.1093/ecco-jcc/jjy008

Raknes G. Relis. Relis-studie om inflammatorisk tarmsykdom: Mindre medisinbruk etter opstart med LDN. Publisert 01.02.2018. https://relis.no/content/4920/RELIS-studie-om-inflammatorisk-tarmsykdom:-Mindre-medisinbruk-etter-oppstart-med-LDN